Cite
APA Citation
Bhattacharya, I., Pawlak, S., Marraffino, S., Christensen, J., Sherlock, S. P., Alvey, C., Morris, C., Arkin, S., & Binks, M. (2018). safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects. Clinical pharmacology in drug development, 7(5), 484–497. http://access.bl.uk/ark:/81055/vdc_100066419680.0x00000d